开元官网登录入口

INGENUITY CREATES MILESTONES

OF INTELLIGENT MANUFACTURING

Toumai® Laparoscopic Surgical Robot Successfully Completed the First Comprehensive Surgical Staging for Endometrial Cancer, Radical Hysterectomy for Type C2 Cervical Cancer and Comprehensive Surgical Staging of Early-stage Ovarian Cancer in the Second Hos
2021-10-16 GMT+8 PM 08:01

In October 2022, Division One of the Gynecology Department of the Second Hospital of Dalian Medical University (“the Second Hospital of Dalian”), led by Jun Wang, Director of the Obstetrics and Gynecology Department and Professor Shichao Han efficiently and successfully completed the first comprehensive surgical staging for endometrial cancer (abdominal aortic lymphadenectomy up to the level of left renal vein), radical hysterectomy for type C2 cervical cancer and comprehensive surgical staging of early-stage ovarian cancer assisted by the domestic Toumai® Laparoscopic Surgical Robot with the cooperation of the Anesthesiology Department and the Operating Room team, paying tribute to the National Day. These surgeries are known as the “Ceiling” in the field of gynecological oncology for its high complexity. Their passion for innovation and new challenges has promoted the development of Chinese developed surgical robots. Before the surgery, Director Jun Wang and Professor Shichao Han accurately assessed the situation of gynecological oncology patients, and grasped the features and technical characteristics of Toumai® Laparoscopic Surgical Robot (“ Toumai®”). As a result, the bloodless surgeries were performed smoothly and accurately, and the patients reported good recovery, thanks to their superb surgical skills optimized in years of practice in the field of gynecological oncology and the perfect team cooperation. The successful implementation of this clinical scientific research project was the first in the clinical application of large high-end medical device in the history of the Second Hospital of Dalian, and also an indication that Toumai®, a high-performance medical device independently developed by China has reached world leading level.

 

On September 27, 2022,  Toumai®, independently developed by Shanghai MicroPort MedBot (Group) Co., Ltd. (“MicroPort® MedBot®”) was introduced to the Division One of the Gynecology Department of the Second Hospital of Dalian, after strict and standard ethic review and argument on its device, scientific research and medicine value by the relevant departments led by secretary Ping Ren and president Zhiyu Liu, and organized by vice presidents Liming Wang and Qi Wang. So far  Toumai® has been successfully applied in various gynecological oncology surgeries. A dozen of surgeries were regularly performed including panhysterectomy, myomectomy, ovarian cyst removal, and adnexectomy. Within half a month, 17 challenging clinical surgeries were performed, setting a precedent for performing challenging gynecologic malignant tumor surgeries assisted by a Chinese developed surgical robot.

 

Director Jun Wang said: “With rapid update and iteration of new technologies and new equipment, we are catching up with and even surpassing the Europe and the US in the field of high-end medical devices. Although the Chinese developed surgical robot system has been successfully marketed, we are still at the early stage in the field of gynecological surgeries. Now a series of gynecological surgeries have been performed with the assistance of Toumai® in this gynecological scientific research project, especially some highly challenging surgeries. This marks a new beginning and a milestone for Chinese developed surgical robots in the field of gynecology.

 

Professor Shichao Han said: “Gynecologic malignant tumors are considered the number one killer of women's health. When a malignant tumor is diagnosed, initial surgical treatment is undoubtedly the most important option to determine the survival and quality of life of the patient and a strong guarantee to improve the prognosis. Therefore, high quality surgical methods in combination with the concept of minimally invasive operation will surely bring benefits for the patients.  Toumai® features flexible instruments to make complex gynecology surgery easier Bloodless surgeries assisted with  Toumai® are performed successfully and smoothly in three fields of malignant tumors, which has proved the outstanding performance of Chinese developed surgical robots.”

 

Since Director Jun Wang of Gynecology Department of the Second Hospital of Dalian performed the first gynecology surgery assisted with surgical robots in Northeast China in 2013, he has been committed to the accurate treatment of benign and malignant tumors for a long time. He participated in the first compilation of Guide on Gynecological Robotic Surgery organized by the State Health and Family Planning Commission, and was awarded the honor of “Award of Outstanding Contribution To the Milestone of 100,000 Surgeries With Da Vinci Surgical System in China” at the 4th Asian Congress of Robotic and Endoscopic Surgery in 2018. He has been invited to deliver lectures on minimal invasive surgery in gynecology to many workshops and session including the Global Minimally Invasive Surgery Forum of Chinese Medical Association, Asia Robotics Annual Conference, Global Symposium on Minimally Invasive Surgical Treatment in Gynecology, Special Technical Training Class of Gynecological Anatomy and “Huashan Forum”.

 

Professor Shichao Han, as a young expert, has delivered special lectures in several large scale academic seminars, and has participated in the live broadcasting of many challenging surgeries process such as cervical cancer and endometrial cancer on international live broadcasting platforms, winning the attention and recognition of peers. In 2021, he won the first place in the preliminary contest and the third place in the final contest of “The 9th Surgical Videos Competition of www.obgy.cn”, as well as the first place in the gynecological laparoscopic robot video contest in Northeast China.

 

Since Director Jun Wang and Professor Shichao Han of the Second Hospital of Dalian performed the first gynecology surgery assisted with surgical robots in Northeast China in 2013, they have performed the first challenging gynecologic malignant tumor surgery assisted by a Chinese developed surgical robot independently developed by China, indicating the gynecologic surgeries of the Second Hospital of Dalian has entered into the era of accurate and minimally invasive robotic surgery. The successful application of Chinese developed surgical robots by Director Jun Wang and Professor Shichao Han demonstrates their leading surgical skills, and is the best proof of the superior safety, effectiveness and stability of the Chinese developed surgical robot.

 

Mr. Yu Liu, Executive Vice President and Chief Commercial Officer of MicroPort® MedBot ®, said, “I am truly grateful for the strong support from the leaders of the Second Hospital of Dalian. I also want to thank the team led by Director Jun Wang and Professor Shichao Han for continuously challenging complicated gynecological surgeries with Toumai®. With the instruction and guidance of the experts, challenging surgeries assisted with Chinese developed surgical robots have been performed normally, and Toumai® has continuously verified the safety and effectiveness of surgeries assisted with robots in different departments.” In future, we will continue to strengthen cooperation with the clinical experts, further innovate and update our products, and provide the doctors and patients with superb robotic intelligent surgical total solutions to "Make Surgery Easier, Safer and Less Invasive”.

 

 

 

For more information,
please click here.